| | | Re: Young Folk Portfolio ... Adjustments
I will be trimming SBUX from an overweight position to a 1/2 sized position. I gave my reasons for this in my previous comment.
With the proceeds of this sale, I will be adding to the following positions in equal amounts.
ABT .. JNJ .. MSFT .. UNH.
In an inflationary and higher interest rate environment, healthcare companies seem to hold up well, and as for MSFT, what can I say, it's MSFT.
As market conditions weaken, I think it more important than ever to stick with strength and the analysts consider these companies among the best of the best under current market conditions. Here are the analyst ratings for each.
ABT:
Credit-Suisse -- Outperform
Argus -- Buy
CFRA -- Buy
Reuters -- Outperform
The Street -- Buy
Jefferson Research -- Strong Buy
Tip Ranks -- Strong Buy with 11 analysts Bullish and 1 Neutral
Wall Street Analysts -- 17 Bullish, 3 Neutral, 1 Bearish
JNJ:
Credit-Suisse -- Outperform
Argus -- Buy
CFRA -- Buy
Reuters -- Outperform
The Street -- Buy
Tip Ranks -- Strong Buy with 6 analysts Bullish and 1 analyst Neutral
Wall Street Analysts -- 9 Bullish and 9 Neutral
MSFT:
Credit-Suisse -- Outperform
Argus -- Buy
CFRA -- Strong Buy
Reuters -- Outperform
The Street -- Buy
Tip Ranks -- Strong Buy with 24 analysts Bullish and 1 Neutral
Wall Street Analysts -- 42 Bullish and 2 Neutral
UNH:
Credit-Suisse -- Outperform
Argus -- Buy
CFRA -- Strong Buy
Reuters -- Outperform
The Street -- Buy
Tip Ranks -- Strong Buy with 13 analysts Bullish and 3 Neutral
Wall Street Analysts -- 22 Bullish, 3 Neutral, 1 Bearish
Again, these were the highest ratings for companies in the taxable account where these adjustments are being made. |
|
